Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitie Share News (MTO)

Share Price Information for Mitie (MTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 117.40
Bid: 117.20
Ask: 117.60
Change: 0.00 (0.00%)
Spread: 0.40 (0.341%)
Open: 117.20
High: 117.60
Low: 115.80
Prev. Close: 117.40
MTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Serco, Mitie win contract extensions for UK COVID-19 test centres

Mon, 28th Jun 2021 07:45

* Serco contract could be worth up to 322 mln stg

* Mitie deal worth up to 365 mln stg

* Contracts run for 12 months with option to extend for 6
more
(Adds Mitie deal, background, detail)

By Yadarisa Shabong

June 28 (Reuters) - Serco and Mitie have won
new testing contracts collectively worth up to 687 million
pounds ($956.1 million) to continue supporting Britain's
much-criticised COVID-19 test-and-trace programme, the groups
said separately on Monday.

The scheme, which Prime Minister Boris Johnson pledged would
be world-beating when he launched it with a 22 billion pound
budget in May 2020, has repeatedly missed targets, with the
opposition Labour Party criticising the government's use of
private firms.

Serco's contract, which is worth up to 322 million pounds,
covers services such as site operations, cleaning and security
at around 20% of test sites in England and Northern Ireland,
down from the roughly 25% of sites covered by its previous deal.

Mitie's deal, worth up to 365 million pounds, covers the
management of around 28% of testing sites across England,
Scotland and Wales, up from about 23% of sites in its former
contract.

The two agreements are focussed on testing only but form
part of the test-and-trace scheme, which oversees testing of
people who think they have COVID-19, and then tracing contacts
of those who test positive to require them to isolate.

While Serco also holds contracts for contact tracing, Mitie
only looks after testing sites.

Parliament's spending watchdog said on Friday the scheme had
improved but was still missing targets, and the results of
millions of tests to find asymptomatic cases had not been
reported.

Britain has the highest COVID-19 death toll in Europe and is
seeing a surge in cases driven by the new Delta variant of the
virus, although an advanced vaccination campaign has kept
hospitalisations and deaths far below previous infection waves.

Serco earlier this month raised its 2021 profit forecast in
part thanks to its work on COVID-19 services. It did not change
its forecast on Monday following the contract win.

"We expect that the margin is slightly below group average,
but in line with expectations," Liberum analysts said on Serco.

Shares in Serco were up 0.7%, while Mitie was down 2.5%.

($1 = 0.7185 pounds)
(Reporting by Yadarisa Shabong in Bengaluru; Editing by Louise
Heavens, Mark Potter and Jan Harvey)

More News
16 Jun 2021 17:31

IN BRIEF: Shareholder in MITIE to sell up to 7.0% stake via placing

IN BRIEF: Shareholder in MITIE to sell up to 7.0% stake via placing

Read more
16 Jun 2021 09:36

BROKER RATINGS: Citigroup upgrades HSBC to Buy from Neutral

BROKER RATINGS: Citigroup upgrades HSBC to Buy from Neutral

Read more
11 Jun 2021 09:08

Mind Gym sees return to profit by 2023 after swinging to loss

Mind Gym sees return to profit by 2023 after swinging to loss

Read more
10 Jun 2021 17:11

LONDON MARKET CLOSE: Stocks mixed as US annual inflation heats up

LONDON MARKET CLOSE: Stocks mixed as US annual inflation heats up

Read more
10 Jun 2021 12:18

LONDON MARKET MIDDAY: US CPI, ECB in focus; NI row rumbles as G7 meets

LONDON MARKET MIDDAY: US CPI, ECB in focus; NI row rumbles as G7 meets

Read more
10 Jun 2021 09:51

Mitie swings to loss but remains buoyant about 2022 outlook

Mitie swings to loss but remains buoyant about 2022 outlook

Read more
10 Jun 2021 08:53

UPDATE 2-UK blue chips end higher as telecoms group BT surges on stake buy

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* AstraZeneca, pharma stocks lead gains* Investors shrug off spike in U.S. inflation* BT tops FTSE 100 after Altice takes 12% stake* FTSE 100...

Read more
10 Jun 2021 07:38

Interserve acquisition drives growth at Mitie as it lifts expectations

(Sharecast News) - Energy services and outsourcing company Mitie reported "good" trading resilience through Covid-19 in its full-year results on Thursday, with revenue, including its share of joint ventures and associates, rising 19.1% to £2.59bn.

Read more
10 Jun 2021 07:38

UPDATE 2-UK's Mitie upbeat on profit as virus-related work, Interserve help

(Adds CEO comments from interview, shares, analyst estimates)By Yadarisa ShabongJune 10 (Reuters) - Britain's Mitie on Thursday predicted its full-year profit would beat current market estimates, as the facilities management provider benefits from ...

Read more
3 Jun 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
17 Mar 2021 14:56

EXECUTIVE CHANGES: Mitie, Pharos and Anpario promote finance chiefs

EXECUTIVE CHANGES: Mitie, Pharos and Anpario promote finance chiefs

Read more
5 Mar 2021 21:23

TRADING UPDATES: AMTE prices IPO; Tritax ups placing to GBP198 million

TRADING UPDATES: AMTE prices IPO; Tritax ups placing to GBP198 million

Read more
4 Mar 2021 13:29

IN BRIEF: GLAS Trust completes sale of 10.5% stake in Mitie Group

IN BRIEF: GLAS Trust completes sale of 10.5% stake in Mitie Group

Read more
3 Mar 2021 21:53

TRADING UPDATES: Team PLC prices IPO; Nostra's Cypress doubles

TRADING UPDATES: Team PLC prices IPO; Nostra's Cypress doubles

Read more
19 Feb 2021 12:07

IN BRIEF: SourceBio Inks Covid Mobile Testing Labs Management Contract

IN BRIEF: SourceBio Inks Covid Mobile Testing Labs Management Contract

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.